Tech Company Financing Transactions
Amfora Funding Round
On 3/24/2021, Amfora landed $6 million in Series B financing from Leaps by Bayer and Spruce Capital Partners.
Transaction Overview
Company Name
Announced On
3/24/2021
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series B
Investors
Leaps by Bayer (Juergen Eckhardt)
Spruce Capital Partners (Ganesh Kishore)
Proceeds Purpose
The proceeds from this financing will also allow us to begin to move forward with the development of crops in addition to soy, such as rice and wheat with improved nutritional profiles that will help to combat the global epidemics in obesity and diabetes while addressing the global crisis in food security and human nutritional needs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Montgomery St. 2190
San Francisco, CA 94104
USA
San Francisco, CA 94104
USA
Phone
Website
Email Address
Not Recorded
Overview
A seismic shift is underway that is challenging the planet's ability to feed its people in a sustainable way. A growing global population, rising prosperity in developing countries, and changing diets are fueling demand for ever-increasing amounts of food, and in particular, foods that are high in protein.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lloyd Kunimoto
Chief Scientific Officer
Michael Lassner
Browse more venture capital transactions:
Prev: 3/24/2021: Language I/O venture capital transaction
Next: 3/25/2021: Hopper venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs